Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
This article is the work product of the Continuous Glucose Monitor and Automated Insulin Dosing Systems in the Hospital Consensus Guideline Panel, which was organized by Diabetes Technology Society and met virtually on April 23, 2020. The guideline panel consisted of 24 international experts in the use of continuous glucose monitors (CGMs) and automated insulin dosing (AID) systems representing adult endocrinology, pediatric endocrinology, obstetrics and gynecology, advanced practice nursing, diabetes care and education, clinical chemistry, bioengineering, and product liability law. The panelists reviewed the medical literature pertaining to five topics: (1) continuation of home CGMs after hospitalization, (2) initiation of CGMs in the hospital, (3) continuation of AID systems in the hospital, (4) logistics and hands-on care of hospitalized patients using CGMs and AID systems, and (5) data management of CGMs and AID systems in the hospital. The panelists then developed three types of recommendations for each topic, including clinical practice (to use the technology optimally), research (to improve the safety and effectiveness of the technology), and hospital policies (to build an environment for facilitating use of these devices) for each of the five topics. The panelists voted on 78 proposed recommendations. Based on the panel vote, 77 recommendations were classified as either strong or mild. One recommendation failed to reach consensus. Additional research is needed on CGMs and AID systems in the hospital setting regarding device accuracy, practices for deployment, data management, and achievable outcomes. This guideline is intended to support these technologies for the management of hospitalized patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have been published assessing the effectiveness of this approach, which may ultimately lead to the approved use of CGM for monitoring hospitalized individuals (277,286-295).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [277]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Similarly, data are emerging on the inpatient use of AID systems and their challenges (277,296,297).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [277]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Because up to 40% to 50% of persons admitted with stress-related hyperglycemia have confirmed DM at 1 year they should be closely monitored after discharge.1378,1379”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1379]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
Work system design for patient safety: the SEIPS model
Carayon, P., Schoofs Hundt, A., Karsh, B.-T., Gurses, A. P., Alvarado, C. J., Smith, M., & Flatley Brennan, P. (2006) · Quality in Health Care · doi:10.1136/qshc.2005.015842 · Cited by 1,795
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Intravascular Complications of Central Venous Catheterization by Insertion Site
Parienti, J.-J., Mongardon, N., Mégarbane, B., Mira, J.-P., Kalfon, P., Gros, A., Marqué, S., Thuong, M., Pottier, V., Ramakers, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500964 · Cited by 769
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
Sardu, C., D’Onofrio, N., Balestrieri, M. L., Barbieri, M., Rizzo, M. R., Messina, V., Maggi, P., Coppola, N., Paolisso, G., & Marfella, R. (2020) · Diabetes Care · doi:10.2337/dc20-0723 · Cited by 424
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Umpierrez, G. E., & Klonoff, D. C. (2018) · Diabetes Care · doi:10.2337/dci18-0002 · Cited by 251
Self-citationFundamentals of Clinical Data Science
(2019) · Springer eBooks · doi:10.1007/978-3-319-99713-1 · Cited by 235
Closed-loop insulin delivery for glycemic control in noncritical care
Bally, L., Thabit, H., Hartnell, S., Andereggen, E., Ruan, Y., Wilinska, M. E., Evans, M. L., Wertli, M. M., Coll, A. P., Stettler, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805233 · Cited by 232
Self-citationReal-Time Continuous Glucose Monitoring in Critically Ill Patients
Holzinger, U., Warszawska, J., Kitzberger, R., Wewalka, M., Miehsler, W., Herkner, H., & Madl, C. (2010) · Diabetes Care · doi:10.2337/dc09-1352 · Cited by 212
Research works printed but not linked: 4
- Price GC, 2008, Crit Care Resusc, 10, 209
- van Steen SCJ, 2017, Sensors, 17
- Revision of the “guideline of the German medical association on quality assurance in medical laboratory examinations – Rili-BAEK” (unauthorized translation), 2015, J Lab Med, 39, 26
- United States Supreme Court, 2001, Official Reports of the Supreme Court, 531
Cited by
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
“Similarly, patients using diabetes devices should be allowed to use them in an inpatient setting or during outpatient procedures when proper supervision is available and the patient/ caregiver is capable of managing the device(s) (283).”
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationHolt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05568-3 · Cited by 378
“Similarly, patients using diabetes devices should be allowed to use them in an inpatient setting or during outpatient procedures when proper supervision is available and the patient/caregiver is capable of managing the device(s) [283].”
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
Self-citation
Metadata
- Authors
- Galindo, R. J., Umpierrez, G. E., Rushakoff, R. J., Basu, A., Lohnes, S., Nichols, J. H., Spanakis, E. K., Espinoza, J., Palermo, N. E., Awadjie, D. G., Bak, L., Buckingham, B., Cook, C. B., Freckmann, G., Heinemann, L., Hovorka, R., Mathioudakis, N., Newman, T., O’Neal, D. N., Rickert, M., Sacks, D. B., Seley, J. J., Wallia, A., Shang, T., Zhang, J. Y., Han, J., & Klonoff, D. C.
- Affiliations
- Emory University (US)
- University of California, San Francisco (US)
- University of Virginia (US)
- University of California San Diego Medical Center (US)
- Vanderbilt University Medical Center (US)
- University of Maryland, Baltimore (US)
- Children's Hospital Los Angeles (US)
- Brigham and Women's Hospital (US)
- NYU Langone Health (US)
- Yale New Haven Hospital (US)
- Stanford Medicine (US)
- Mayo Clinic in Arizona (US)
- Institut für Diabetes-Technologie (Germany) (DE)
- Science Consulting in Diabetes GmbH, Neuss, Germany
- University of Cambridge (GB)
- Johns Hopkins University (US)
- Neal, Gerber and Eisenberg LLP, Chicago, IL, USA
- University of Melbourne Department of Medicine, St. Vincent’s Hospital, Fitzroy, Victoria, Australia
- Oregon Health & Science University (US)
- National Institutes of Health (US)
- Weill Cornell Medicine (US)
- Northwestern University (US)
- Diabetes Technology Society (US)
- Mills Peninsula Health Services (US)
- Corresponding author
- Klonoff, David C.
- ORCID
- Galindo, Rodolfo J.
- Umpierrez, Guillermo E.
- Rushakoff, Robert J.
- Basu, Ananda
- Nichols, James H.
- Spanakis, Elias K.
- Espinoza, Juan
- Palermo, Nadine E.
- Buckingham, Bruce
- Cook, Curtiss B.
- Freckmann, Guido
- Heinemann, Lutz
- Hovorka, Roman
- Mathioudakis, Nestoras
- O’Neal, David N.
- Rickert, Michaela
- Sacks, David B.
- Seley, Jane Jeffrie
- Wallia, Amisha
- Shang, Trisha
- Zhang, Jennifer Y.
- Han, Julia
- Klonoff, David C.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2020-09-28
- Volume
- 14
- Issue
- 6
- Pages
- 1035-1064
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC7645140
- OpenAlex
- W3089189812
- Cited by
- 170
- References
- 127
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 27 · 2023: 27 · 2022: 25 · 2021: 23 · 2020: 2
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- abbott diabetes care
- dexcom
- medtronic
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, artificial pancreas, hospitalized patients, diabetes management, hospital care, device accuracy, hospital policy, clinical guidelines, diabetes technology
- MeSH terms
- Adult, Blood Glucose, Child, Diabetes Mellitus, Female, Hospitalization, Hospitals, Humans, Insulin, Insulin Infusion Systems, Pregnancy, Blood Glucose Self-Monitoring, Consensus, Diabetes Complications, Drug Dosage Calculations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. https://app.cochat.ai/papers/10.1177/1932296820954163
- The paper
- Galindo, R. J., Umpierrez, G. E., Rushakoff, R. J., Basu, A., Lohnes, S., Nichols, J. H., Spanakis, E. K., Espinoza, J., Palermo, N. E., Awadjie, D. G., Bak, L., Buckingham, B., Cook, C. B., Freckmann, G., Heinemann, L., Hovorka, R., Mathioudakis, N., Newman, T., O’Neal, D. N., . . . Klonoff, D. C. (2020). Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820954163
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.